These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18231839)

  • 1. Tuberculosis transmission model with chemoprophylaxis and treatment.
    Bhunu CP; Garira W; Mukandavire Z; Zimba M
    Bull Math Biol; 2008 May; 70(4):1163-91. PubMed ID: 18231839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control.
    Bhunu CP; Garira W; Mukandavire Z; Magombedze G
    J Theor Biol; 2008 Oct; 254(3):633-49. PubMed ID: 18644386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theoretical assessment of the effects of smoking on the transmission dynamics of tuberculosis.
    Bhunu CP; Mushayabasa S; Tchuenche JM
    Bull Math Biol; 2011 Jun; 73(6):1333-57. PubMed ID: 20725798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for tuberculosis with exogenous reinfection.
    Feng Z; Castillo-Chavez C; Capurro AF
    Theor Popul Biol; 2000 May; 57(3):235-47. PubMed ID: 10828216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions.
    Gabriela M Gomes M; Rodrigues P; Hilker FM; Mantilla-Beniers NB; Muehlen M; Cristina Paulo A; Medley GF
    J Theor Biol; 2007 Oct; 248(4):608-17. PubMed ID: 17669435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment.
    Domínguez J; De Souza-Galvão M; Ruiz-Manzano J; Latorre I; Prat C; Lacoma A; Milà C; Jiménez MA; Blanco S; Maldonado J; Altet N; Ausina V
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):43-51. PubMed ID: 19026511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for patients with pulmonary tuberculosis.
    Wang B; Lu Y; Yu L; Liu C; Liu X; Wu Z; Zhu HT; Pan CE
    Transpl Infect Dis; 2009 Apr; 11(2):128-31. PubMed ID: 19210689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in liver transplant recipients: a single Brazilian center experience.
    Clemente WT; Faria LC; Lima SS; Vilela EG; Lima AS; Velloso LF; Sanches MD; Cançado OL
    Transplantation; 2009 Feb; 87(3):397-401. PubMed ID: 19202445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model.
    Clark M; Cameron DW
    Int J Infect Dis; 2009 Mar; 13(2):220-6. PubMed ID: 19185525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis and tuberculosis/HIV co-infection in pregnancy.
    Adhikari M
    Semin Fetal Neonatal Med; 2009 Aug; 14(4):234-40. PubMed ID: 19303830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underuse of effective measures to prevent and manage pediatric tuberculosis in the United States.
    Lobato MN; Sun SJ; Moonan PK; Weis SE; Saiman L; Reichard AA; Feja K;
    Arch Pediatr Adolesc Med; 2008 May; 162(5):426-31. PubMed ID: 18458188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of tuberculosis carriers. Individual and collective medical significance].
    Haegi V
    Bibl Tuberc; 1969; 25():35-42. PubMed ID: 5344370
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi.
    Yu JK; Bong CN; Chen SC; Dzimadzi R; Lu DY; Makombe SD; Schouten EJ; Kamoto K; Harries AD
    Int J Tuberc Lung Dis; 2008 Jun; 12(6):692-4. PubMed ID: 18492340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study.
    Faustini A; Hall AJ; Mantovani J; Sangalli M; Perucci CA;
    Int J Infect Dis; 2008 Nov; 12(6):611-21. PubMed ID: 18395482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
    Yu DH; Hu XD; Cai H
    Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.